{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:40:04Z","timestamp":1792136404193,"version":"4.4.0"},"reference-count":255,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:00:00Z","timestamp":1536278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100006474","name":"Columbia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006474","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["World Psychiatry"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>The benefits of antipsychotic medications are sometimes obscured by their adverse effects. These effects range from relatively minor tolerability issues (e.g., mild sedation or dry mouth) to very unpleasant (e.g., constipation, akathisia, sexual dysfunction) to painful (e.g., acute dystonias) to disfiguring (e.g., weight gain, tardive dyskinesia) to life\u2010threatening (e.g., myocarditis, agranulocytosis). Importantly, adverse effect profiles are specific to each antipsychotic medication and do not neatly fit into first\u2010 and second\u2010generation classifications. This paper reviews management strategies for the most frequent side effects and identifies common principles intended to optimize net antipsychotic benefits. Only use antipsychotics if the indication is clear; only continue antipsychotics if a benefit is discernible. If an antipsychotic is providing substantial benefit, and the adverse effect is not life\u2010threatening, then the first management choice is to lower the dose or adjust the dosing schedule. The next option is to change the antipsychotic; this is often reasonable unless the risk of relapse is high. In some instances, behavioral interventions can be tried. Finally, concomitant medications, though generally not desirable, are necessary in many instances and can provide considerable relief. Among concomitant medication strategies, anticholinergic medications for dystonias and parkinsonism are often effective; beta\u2010blockers and anticholinergic medications are useful for akathisia; and metformin may lead to slight to moderate weight loss. Anticholinergic drops applied sublingually reduce sialorrhea. Usual medications are effective for constipation or dyslipidemias. The clinical utility of recently approved treatments for tardive dyskinesia, valbenazine and deutetrabenazine, is unclear.<\/jats:p>","DOI":"10.1002\/wps.20567","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T09:57:19Z","timestamp":1536314239000},"page":"341-356","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":516,"title":["Management of common adverse effects of antipsychotic medications"],"prefix":"10.1002","volume":"17","author":[{"given":"T. Scott","family":"Stroup","sequence":"first","affiliation":[{"name":"New York State Psychiatric Institute Columbia University College of Physicians and Surgeons  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, John A. Burns School of Medicine University of Hawaii  Honolulu HI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,9,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.4311"},{"key":"e_1_2_8_3_1","unstructured":"International College of Neuropsychopharmacology.CINP schizophrenia guidelines.http:\/\/cinp.org\/cinp-schizophrenia-guidelines\/."},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e32835dcc2a"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12028ah1"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10111609"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0208"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1309004"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198300061-00004"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7210.623"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.1.85"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.12.1819"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.132.5.532"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(89)72240-4"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000411"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.8.993"},{"key":"e_1_2_8_17_1","first-page":"106","article-title":"The effect of benztropine on haloperidol\u2010induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double\u2010blind trial","volume":"11","author":"Goff DC","year":"1991","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432269"},{"key":"e_1_2_8_19_1","first-page":"706","article-title":"Prevention of acute dystonic reactions in patients beginning high\u2010potency neuroleptics","volume":"143","author":"Winslow RS","year":"1986","journal-title":"Am J Psychiatry"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770200080009"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125314553611"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/00048678609161335"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108096070"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1987.tb02942.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.135.10.1232"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2008.073312"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.9.4.562"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.11.1558"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199901)14:1<128::AID-MDS1021>3.0.CO;2-J"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0600-5"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-016-0416-8"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2016.08.017"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199920030-00006"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0b013e318160864f"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/030006058000800507"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.9.9.1451"},{"key":"e_1_2_8_37_1","first-page":"323","article-title":"Amantadine in drug\u2010induced extrapyramidal signs: a comparative study","volume":"11","author":"Ananth J","year":"1975","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"e_1_2_8_38_1","first-page":"147","article-title":"Ethopropazine and benztropine in neuroleptic\u2010induced parkinsonism","volume":"40","author":"Chouinard G","year":"1979","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1159\/000136523"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700045220"},{"key":"e_1_2_8_41_1","first-page":"167","article-title":"No difference in the effect of biperiden and amantadine on parkinsonian\u2010 and tardive dyskinesia\u2010type involuntary movements: a double\u2010blind crossover, placebo\u2010controlled study in medicated chronic schizophrenic patients","volume":"56","author":"Silver H","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198300061-00005"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(96)00041-7"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950120035007"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4646-1"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.109.070540"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.12.007"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.149.1.42"},{"key":"e_1_2_8_49_1","first-page":"107","article-title":"Treatment of neuroleptic\u2010induced akathisia with propranolol: a controlled replication study","volume":"11","author":"Kramer MS","year":"1989","journal-title":"Hillside J Clin Psychiatry"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(88)90260-0"},{"key":"e_1_2_8_51_1","first-page":"CD001946","article-title":"Central action beta\u2010blockers versus placebo for neuroleptic\u2010induced acute akathisia","volume":"4","author":"Lima AR","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_52_1","first-page":"CD003727","article-title":"Anticholinergics for neuroleptic\u2010induced acute akathisia","volume":"4","author":"Rathbone J","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199002000-00003"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K672"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125315601343"},{"key":"e_1_2_8_56_1","first-page":"373","article-title":"Treatment of neuroleptic induced akathisia with the 5\u2010HT2 antagonist ritanserin","volume":"26","author":"Miller CH","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(92)90076-Q"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199806000-00013"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.174.3.238"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2009.02.006"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200112000-00013"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0610"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1017074"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198912000-00003"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199406000-00003"},{"key":"e_1_2_8_66_1","first-page":"CD001950","article-title":"Benzodiazepines for neuroleptic\u2010induced acute akathisia","volume":"1","author":"Lima AR","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15050618"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1118"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1990.tb28058.x"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2010.10.007"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2008.08.003"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2003.11.011"},{"key":"e_1_2_8_73_1","first-page":"162","article-title":"Medication\u2010induced tardive dyskinesia: a review and update","volume":"17","author":"Cornett EM","year":"2017","journal-title":"Ochsner J"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2010.103234"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/18.4.701"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.8.1438"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22707"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.07.034"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1590-8"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4002142"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2010.486043"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.12.011"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3282f70492"},{"key":"e_1_2_8_84_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.16.26"},{"key":"e_1_2_8_85_1","doi-asserted-by":"publisher","DOI":"10.3109\/08039488.2013.780260"},{"key":"e_1_2_8_86_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.16r10832"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e3282f53132"},{"key":"e_1_2_8_88_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.3.414"},{"key":"e_1_2_8_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4399"},{"key":"e_1_2_8_90_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200503000-00003"},{"key":"e_1_2_8_91_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05155yel"},{"key":"e_1_2_8_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199506000-00017"},{"key":"e_1_2_8_93_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta21430"},{"key":"e_1_2_8_94_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.16091037"},{"key":"e_1_2_8_95_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P312"},{"key":"e_1_2_8_96_1","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1176\/ajp.156.8.1279","article-title":"Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol","volume":"156","author":"Ondo WG","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_8_97_1","article-title":"Valbenazine for tardive dyskinesia: a systematic review of the efficacy and safety profile for this newly approved novel medication \u2013 what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?","author":"Citrome L","journal-title":"Int J Clin Pract"},{"key":"e_1_2_8_98_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003960"},{"key":"e_1_2_8_99_1","first-page":"CD000203","article-title":"Gamma\u2010aminobutyric acid agonists for neuroleptic\u2010induced tardive dyskinesia","volume":"4","author":"Alabed S","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_100_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.4.445"},{"key":"e_1_2_8_101_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05125yel"},{"key":"e_1_2_8_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.04.032"},{"key":"e_1_2_8_103_1","first-page":"CD010501","article-title":"Pyridoxal 5 phosphate for neuroleptic\u2010induced tardive dyskinesia","volume":"4","author":"Adelufosi AO","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_104_1","first-page":"CD000209","article-title":"Vitamin E for neuroleptic\u2010induced tardive dyskinesia","volume":"2","author":"Soares\u2010Weiser K","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_105_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31829d86b6"},{"key":"e_1_2_8_106_1","first-page":"CD000458","article-title":"Non\u2010neuroleptic catecholaminergic drugs for neuroleptic\u2010induced tardive dyskinesia","volume":"1","author":"El\u2010Sayeh HG","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_107_1","first-page":"CD000206","article-title":"Calcium channel blockers for neuroleptic\u2010induced tardive dyskinesia","volume":"11","author":"Essali A","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_108_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002370"},{"key":"e_1_2_8_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-53497-2.00015-2"},{"key":"e_1_2_8_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pjnns.2016.01.004"},{"key":"e_1_2_8_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-381328-2.00012-2"},{"key":"e_1_2_8_112_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125316641019"},{"key":"e_1_2_8_113_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.167.3.412a"},{"key":"e_1_2_8_114_1","first-page":"148","article-title":"Muscarinic supersensitivity and subsensitivity induced by chronic treatment with atropine and diisopropylfluorophosphate in rat submaxillary glands","volume":"297","author":"Ukai Y","year":"1989","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_2_8_115_1","doi-asserted-by":"publisher","DOI":"10.3371\/CSRP.SAFI.061213"},{"key":"e_1_2_8_116_1","first-page":"20","article-title":"Sialorrhea and aspiration pneumonia: a case study","volume":"10","author":"Trigoboff E","year":"2013","journal-title":"Innov Clin Neurosci"},{"key":"e_1_2_8_117_1","first-page":"704","article-title":"Two cases of parotid gland swelling in patients taking clozapine","volume":"62","author":"Acosta\u2010Armas AJ","year":"2001","journal-title":"Hosp Med"},{"key":"e_1_2_8_118_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v57n1007e"},{"key":"e_1_2_8_119_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P761"},{"key":"e_1_2_8_120_1","first-page":"CD009546","article-title":"Anticholinergic medication for non\u2010clozapine neuroleptic\u2010induced hypersalivation in people with schizophrenia","volume":"12","author":"Essali A","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_121_1","first-page":"250","article-title":"Clozapine and sialorrhea: a new intervention for this bothersome and potentially dangerous side effect","volume":"24","author":"Antonello C","year":"1999","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_2_8_122_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E077"},{"key":"e_1_2_8_123_1","first-page":"253","article-title":"Clozapine and sialorrhea: update","volume":"26","author":"Tessier P","year":"2001","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_2_8_124_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200015010-00008"},{"key":"e_1_2_8_125_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000106228.36344.2e"},{"key":"e_1_2_8_126_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04495"},{"key":"e_1_2_8_127_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199917020-00003"},{"key":"e_1_2_8_128_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199707000-00005"},{"key":"e_1_2_8_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.02.1060"},{"key":"e_1_2_8_130_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200112000-00012"},{"key":"e_1_2_8_131_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-815523"},{"key":"e_1_2_8_132_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.159.1.166a"},{"key":"e_1_2_8_133_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199202000-00026"},{"key":"e_1_2_8_134_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105053311"},{"key":"e_1_2_8_135_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000145348.06783.1d"},{"key":"e_1_2_8_136_1","first-page":"61","article-title":"Sulpiride addition for the treatment of clozapine\u2010induced hypersalivation: preliminary study","volume":"42","author":"Kreinin A","year":"2005","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"e_1_2_8_137_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2010.527370"},{"key":"e_1_2_8_138_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000188216.92408.69"},{"key":"e_1_2_8_139_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e31818f1111"},{"key":"e_1_2_8_140_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-1803-0"},{"key":"e_1_2_8_141_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1689-y"},{"key":"e_1_2_8_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3"},{"key":"e_1_2_8_143_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12001"},{"issue":"2","key":"e_1_2_8_144_1","first-page":"3","article-title":"Atypical antipsychotics: sleep, sedation, and efficacy","volume":"6","author":"Miller DD","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"e_1_2_8_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2014.09.013"},{"key":"e_1_2_8_146_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.12.1900"},{"key":"e_1_2_8_147_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199208000-00010"},{"key":"e_1_2_8_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00258-3"},{"key":"e_1_2_8_149_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0420h"},{"key":"e_1_2_8_150_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.07r03982"},{"key":"e_1_2_8_151_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04683"},{"key":"e_1_2_8_152_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.9.1231b"},{"key":"e_1_2_8_153_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.12100246"},{"key":"e_1_2_8_154_1","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2016.14.3.238"},{"key":"e_1_2_8_155_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198105283042214"},{"key":"e_1_2_8_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2016.03.018"},{"key":"e_1_2_8_157_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1347177"},{"key":"e_1_2_8_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.08.037"},{"key":"e_1_2_8_159_1","first-page":"143","article-title":"Antipsychotic\u2010induced hyperprolactinemia and sexual dysfunction","volume":"36","author":"Compton MT","year":"2002","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_8_160_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328341e434"},{"key":"e_1_2_8_161_1","first-page":"CD003546","article-title":"Management of sexual dysfunction due to antipsychotic drug therapy","volume":"1","author":"Berner MM","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_162_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-10-1"},{"key":"e_1_2_8_163_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12313"},{"key":"e_1_2_8_164_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.023671"},{"key":"e_1_2_8_165_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000062"},{"key":"e_1_2_8_166_1","doi-asserted-by":"publisher","DOI":"10.1159\/000356498"},{"key":"e_1_2_8_167_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12459"},{"key":"e_1_2_8_168_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2010.03814.x"},{"key":"e_1_2_8_169_1","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman AF","year":"2004","journal-title":"Am J Psychiatry"},{"key":"e_1_2_8_170_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107087346"},{"key":"e_1_2_8_171_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-003-1454-8"},{"key":"e_1_2_8_172_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.6356"},{"key":"e_1_2_8_173_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05154yel"},{"key":"e_1_2_8_174_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2007.11.002"},{"key":"e_1_2_8_175_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-31802006000500012"},{"key":"e_1_2_8_176_1","doi-asserted-by":"publisher","DOI":"10.2165\/11591710-000000000-00000"},{"key":"e_1_2_8_177_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1424"},{"key":"e_1_2_8_178_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.10.011"},{"key":"e_1_2_8_179_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02142.x"},{"key":"e_1_2_8_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.04.003"},{"key":"e_1_2_8_181_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-007-1003-1"},{"key":"e_1_2_8_182_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.77a.09118"},{"key":"e_1_2_8_183_1","first-page":"497","article-title":"Clozapine\u2010induced orthostatic hypotension treated with fludrocortisone","volume":"55","author":"Testani M","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_8_184_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.23.1445"},{"key":"e_1_2_8_185_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-0805-y"},{"key":"e_1_2_8_186_1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.12.2.285"},{"key":"e_1_2_8_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2015.07.015"},{"key":"e_1_2_8_188_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806994"},{"key":"e_1_2_8_189_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.12.1293"},{"key":"e_1_2_8_190_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001568"},{"key":"e_1_2_8_191_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1991.tb01421.x"},{"key":"e_1_2_8_192_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.180.6.515"},{"key":"e_1_2_8_193_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.12.1161"},{"key":"e_1_2_8_194_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262110-00006"},{"key":"e_1_2_8_195_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2005.07.017"},{"key":"e_1_2_8_196_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0809417"},{"key":"e_1_2_8_197_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pra.0000450319.21859.6d"},{"key":"e_1_2_8_198_1","unstructured":"LiebermanJA MerrillD ParameswaranS.APA guidance on the use of antipsychotic drugs and cardiac sudden death.https:\/\/www.omh.ny.gov."},{"key":"e_1_2_8_199_1","volume-title":"Guidance on the use of antipsychotics, Version 3.2","author":"Kavanaugh G","year":"2015"},{"key":"e_1_2_8_200_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028016657553"},{"key":"e_1_2_8_201_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.111.105189"},{"key":"e_1_2_8_202_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200923060-00003"},{"key":"e_1_2_8_203_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674371205700810"},{"key":"e_1_2_8_204_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.6.870"},{"key":"e_1_2_8_205_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12222"},{"key":"e_1_2_8_206_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X13999150424113345"},{"key":"e_1_2_8_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00109-7"},{"key":"e_1_2_8_208_1","doi-asserted-by":"publisher","DOI":"10.4103\/2229-516X.136800"},{"key":"e_1_2_8_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90138-F"},{"key":"e_1_2_8_210_1","first-page":"49","article-title":"Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome","volume":"56","author":"Patel AL","year":"2008","journal-title":"J Assoc Physicians India"},{"key":"e_1_2_8_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30278-4"},{"key":"e_1_2_8_212_1","doi-asserted-by":"publisher","DOI":"10.1177\/106002808802200606"},{"key":"e_1_2_8_213_1","first-page":"295","article-title":"Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients","volume":"50","author":"Rosebush PI","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_8_214_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1614.1999.00630.x"},{"key":"e_1_2_8_215_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)90206-8"},{"key":"e_1_2_8_216_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307153290303"},{"key":"e_1_2_8_217_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(82)90190-8"},{"key":"e_1_2_8_218_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195902192600806"},{"key":"e_1_2_8_219_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1955.00250150070007"},{"key":"e_1_2_8_220_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.04.025"},{"key":"e_1_2_8_221_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2003.03.009"},{"key":"e_1_2_8_222_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.6.576"},{"key":"e_1_2_8_223_1","doi-asserted-by":"publisher","DOI":"10.1089\/104454603322572697"},{"key":"e_1_2_8_224_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0013-7006(04)95473-5"},{"key":"e_1_2_8_225_1","doi-asserted-by":"publisher","DOI":"10.1002\/pnp.427"},{"key":"e_1_2_8_226_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1993.tb00789.x"},{"key":"e_1_2_8_227_1","first-page":"256","article-title":"Filgrastim treatment of three patients with clozapine\u2010induced agranulocytosis","volume":"56","author":"Lamberti JS","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_8_228_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.encep.2016.03.005"},{"key":"e_1_2_8_229_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2013.11.005"},{"key":"e_1_2_8_230_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.110.084996"},{"key":"e_1_2_8_231_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20757"},{"key":"e_1_2_8_232_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0023795"},{"key":"e_1_2_8_233_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000634"},{"key":"e_1_2_8_234_1","doi-asserted-by":"publisher","DOI":"10.4306\/pi.2013.10.2.200"},{"key":"e_1_2_8_235_1","doi-asserted-by":"publisher","DOI":"10.2174\/157488611794480016"},{"key":"e_1_2_8_236_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730010-00005"},{"key":"e_1_2_8_237_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.01.017"},{"key":"e_1_2_8_238_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091217415621269"},{"key":"e_1_2_8_239_1","doi-asserted-by":"publisher","DOI":"10.1177\/1039856215604480"},{"key":"e_1_2_8_240_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12425"},{"key":"e_1_2_8_241_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867412449062"},{"key":"e_1_2_8_242_1","doi-asserted-by":"publisher","DOI":"10.3371\/1935-1232-10.2.120"},{"issue":"4","key":"e_1_2_8_243_1","first-page":"19","article-title":"Behavioral therapy for weight loss in patients with schizophrenia","volume":"68","author":"Ganguli R","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_8_244_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214530"},{"key":"e_1_2_8_245_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.14030357"},{"key":"e_1_2_8_246_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.14020173"},{"key":"e_1_2_8_247_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.07010079"},{"key":"e_1_2_8_248_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2007.56-b"},{"key":"e_1_2_8_249_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12010127"},{"key":"e_1_2_8_250_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.03.029"},{"key":"e_1_2_8_251_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000192"},{"issue":"2","key":"e_1_2_8_252_1","first-page":"20","article-title":"Managing anticholinergic side effects","volume":"6","author":"Lieberman JA","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"e_1_2_8_253_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbq137"},{"key":"e_1_2_8_254_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0448-6"},{"key":"e_1_2_8_255_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.84a.15141"},{"key":"e_1_2_8_256_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051688"}],"container-title":["World Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fwps.20567","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/wps.20567","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/wps.20567","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/wps.20567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T17:56:28Z","timestamp":1694195788000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/wps.20567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,7]]},"references-count":255,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1002\/wps.20567"],"URL":"https:\/\/doi.org\/10.1002\/wps.20567","archive":["Portico"],"relation":{},"ISSN":["1723-8617","2051-5545"],"issn-type":[{"value":"1723-8617","type":"print"},{"value":"2051-5545","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,7]]},"assertion":[{"value":"2018-06-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}